The Code has been prepared by the Irish Pharmaceutical Healthcare Association (IPHA) with a view to securing the universal acceptance and adoption of high standards of conduc tin the marketing of medicinal products to healthcare professionals, whether intended for use under medical supervision or otherwise.
The advertising of medicinal products for human use in European Union Member States is governed by Council Directive 2001/83/EC of 6 November 2001 as amended. This Code of Practice fits into the general framework established by Article 97 Paragraph 5 of Directive 2001/83/EC as amended, which recognises the role of voluntary control of advertising of medicinal products by self-regulatory bodies and recourse to such bodies.
The Code emphasises the importance of providing healthcare professionals with accurate,fair and objective information about medicinal products so that rational decisions can be made as to their use. Moreover,the Code accepts the principle that such information must be presented in a form and by ways and means which conform not only to legal requirements but also to professional standards of ethics and good taste.
Acceptance and observance of the provisions of the Code and its annexes are a condition of membership of the Irish Pharmaceutical Healthcare Association. Companies observing the Code also acknowledge that its provisions are to be applied in spirit, as well as in the letter.Code of Marketing Practice for the Pharmaceutical Industry The provisions of the Code fully reflect the standards of the June 2011 edition of the “EFPIA Code on the Promotion of Prescription-only Medicines to, and Interactions with, Healthcare Professionals” which is published by the European Federation of Pharmaceutical Industries and Associations(EFPIA). IPHA is a member of EFPIA. Compliance with the European Code is a requirement of all member associations of EFPIA.
This Edition of the Code of Marketing Practice incorporates changes arising from the Medicinal Products(Control of Advertising) Regulations 2007 (S.I. 541 of 2007) for the purposes of providing practical guidance in implementing the Regulations. The Minister for Health and Children, as provided for under Regulation 26 of the Medicinal Products(Control of Advertising) Regulations 2007, hereby endorses the parts of the IPHA Code of Marketing Practice for the Pharmaceutical Industry, 7th Edition,that are directly derived (verbatim)from the Medicinal Products(Control of Advertising) Regulations 2007.
This Code has been provided to help in implementing the requirements of the Regulations. It is designed to be used in conjunction with the Regulations and is, by no means, a substitute for the Regulations.